SpyGlass Pharma Inc
NASDAQ:SGP
SpyGlass Pharma Inc
NASDAQ:SGP
Price:
28.05
USD
-4.36%
Market Closed
Market Cap:
$937.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SpyGlass Pharma Inc
NASDAQ:SGP
|
US |
|
Energy Transfer LP
NYSE:ET
|
US |
|
S
|
Severn Trent PLC
OTC:STRNY
|
UK |
|
Arcosa Inc
NYSE:ACA
|
US |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
T
|
Tesla Inc
DUS:TL0
|
US |
|
B
|
Borgwarner Inc
F:BGW
|
US |
|
W
|
Wendy's Co
XMUN:TQK
|
US |
|
V
|
Vertex Pharmaceuticals Inc
XETRA:VX1
|
US |
|
U
|
Universal Health Realty Income Trust
F:WY8
|
US |
|
R
|
Resonac Holdings Corp
DUS:SWD
|
JP |
|
H
|
Hershey Co
DUS:HSY
|
US |
|
N
|
Nissan Chemical Corp
DUS:NSC
|
JP |
|
F
|
Franklin Resources Inc
DUS:FRK
|
US |
|
Q
|
QinetiQ Group PLC
DUS:QY6
|
UK |
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
US |
|
N
|
Netflix Inc
XHAM:NFC
|
US |
|
Citizens Inc
F:YCX
|
US |
|
S
|
Stainless Tankers ASA
F:ZC0
|
NO |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of SGP.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SGP
Multiples-Based Value
Base Case
Not Available